COVID-19: Up to 82% critically ill patients had low Vitamin C values

There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasa-Irriguible, Teresa Maria, Bielsa-Berrocal, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269403/
https://www.ncbi.nlm.nih.gov/pubmed/34243781
http://dx.doi.org/10.1186/s12937-021-00727-z
Descripción
Sumario:There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.

Ejemplares similares